Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timna Naftali

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|January 8, 2020
Early Surgery Versus Biologic Therapy in Limited Nonstricturing Ileocecal Crohn's Disease-A Decision-making AnalysisEfrat Broide, Adi Eindor-Abarbanel, Timna Naftali, et al.
Inflammatory Bowel Diseases|August 23, 2023
Upadacitinib for Acute Severe Ulcerative ColitisChen Hasya Zinger, Yehuda Ringel, Mayan Eitan, et al.
Plos One|February 11, 2021
Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trialTimna Naftali, Lihi Bar-Lev Schleider, Fabiana Scklerovsky Benjaminov, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 8, 2013
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled studyTimna Naftali, Lihi Bar-Lev Schleider, Iris Dotan, et al.
Rambam Maimonides Medical Journal|April 30, 2025
Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel SyndromeVered Richter, Efrat Broide, Tzippora Shalem, et al.
Digestive Diseases and Sciences|February 23, 2015
Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel DiseaseDoron Yablecovitch, Assaf Stein, Maytal Shabat-Simon, et al.
Digestive Diseases and Sciences|March 29, 2017
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled TrialTimna Naftali, Refael Mechulam, Amir Marii, et al.
Journal of Clinical Medicine|November 27, 2024
Upper and Lower Endoscopic Findings in Mesenteric Panniculitis Patients: A Case-Control StudyHagai Schweistein, Yoav Weintraub, Tzipi Hornik-Lurie, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 7, 2015
Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel diseaseIdo Laish, Hila Katz, Assaf Stein, et al.
Frontiers in Endocrinology|September 17, 2021
Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis ConsumptionShelly Tartakover Matalon, Shahar Azar, David Meiri, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|January 8, 2020
Early Surgery Versus Biologic Therapy in Limited Nonstricturing Ileocecal Crohn's Disease-A Decision-making AnalysisEfrat Broide, Adi Eindor-Abarbanel, Timna Naftali, et al.
Inflammatory Bowel Diseases|August 23, 2023
Upadacitinib for Acute Severe Ulcerative ColitisChen Hasya Zinger, Yehuda Ringel, Mayan Eitan, et al.
Plos One|February 11, 2021
Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trialTimna Naftali, Lihi Bar-Lev Schleider, Fabiana Scklerovsky Benjaminov, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 8, 2013
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled studyTimna Naftali, Lihi Bar-Lev Schleider, Iris Dotan, et al.
Rambam Maimonides Medical Journal|April 30, 2025
Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel SyndromeVered Richter, Efrat Broide, Tzippora Shalem, et al.
Digestive Diseases and Sciences|February 23, 2015
Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel DiseaseDoron Yablecovitch, Assaf Stein, Maytal Shabat-Simon, et al.
Digestive Diseases and Sciences|March 29, 2017
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled TrialTimna Naftali, Refael Mechulam, Amir Marii, et al.
Journal of Clinical Medicine|November 27, 2024
Upper and Lower Endoscopic Findings in Mesenteric Panniculitis Patients: A Case-Control StudyHagai Schweistein, Yoav Weintraub, Tzipi Hornik-Lurie, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 7, 2015
Telomere dysfunction in peripheral blood lymphocytes from patients with primary sclerosing cholangitis and inflammatory bowel diseaseIdo Laish, Hila Katz, Assaf Stein, et al.
Frontiers in Endocrinology|September 17, 2021
Endocannabinoid Levels in Ulcerative Colitis Patients Correlate With Clinical Parameters and Are Affected by Cannabis ConsumptionShelly Tartakover Matalon, Shahar Azar, David Meiri, et al.
Pageof 7